Significance of FNAC , BRAF mutation, and intraoperative frozen section in surgical decision‐making of thyroid nodules
Diagnostic Cytopathology · 2023
DOI: 10.1002/dc.25135 ↗At a glance
Journal article in Diagnostic Cytopathology, 2023. Written by Zhaohui Zhu and 7 co-authors. Institution: Department of Thyroid and Breast Surgery, The Affiliated Huaian Hospital of Xuzhou Medical University, Huaian, China. Major MEDLINE topics: Thyroid Nodule, Thyroid Neoplasms. Cited 4 times so far (Crossref); 43 references.
Abstract (original language)
Background
A preoperative method is desired to discriminate benign from malignant thyroid nodules. This retrospective study evaluated the diagnostic performance of BRAF (B‐Raf proto‐oncogene) mutation ( BRAF V600E ) positivity and fine‐needle aspiration cytology (FNAC) relative to intraoperative frozen section pathology.
Methods
Patients underwent preoperative FNAC of thyroid nodules. Cytology specimens were classified according to the Bethesda System for Reporting Thyroid Cytopathology (BSRTC), and analyzed for BRAF V600E using an amplification‐refractory mutation system (ARMS). Thyroid tissue was surgically removed and frozen sections processed for histology. The sensitivities and specificities of each analysis were compared, alone and in combination.
Results
Among 346 patients, 333/358 FNACs (93%) showed malignant nodules; 322 (93%) patients received a pathological diagnosis of papillary thyroid carcinoma (PTC). The sensitivity and specificity of BSRTC VI for malignancy was the highest among the BSRTC categories. Compared with FNAC, the BRAF V600E analysis had significantly higher sensitivity and specificity. The diagnostic efficacy of frozen section pathology was significantly higher than that of either BSRTC category or BRAF V600E analysis alone. Combining methods variably improved diagnostic performance. BRAF V600E was not associated with capsule infiltration, neurovascular infiltration, mono‐ or multifocal PTC, lymph node metastasis, or clinical stage.
Conclusion
The diagnostic performance of preoperative BRAF V600E determination was better than that of the BSRTC‐FNAC category; combining both improved sensitivity and specificity. Patients with positive malignancy scores from both should be recommended for surgery; those with negative scores require close monitoring. Surgical treatment should include comprehensive intraoperative frozen section assessment. BRAF mutations cannot indicate aggressive treatment.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Thyroid and Breast Surgery, The Affiliated Huaian Hospital of Xuzhou Medical University, Huaian, China.
- Department of General Surgery Center, The First Hospital of Jilin University, Changchun, China.
- Department of Pathology, The First Hospital of Jilin University, Changchun, China.
- Department of Laboratory Medicine, The First Hospital of Jilin University, Changchun, China.
ORCID profiles: Zhaohui Zhu
Cite
APA
Zhu, Z., Su, C., Chen, G., Wan, F., Jin, M., Duan, X., Wang, Y., & Wang, G. (2023). Significance of FNAC , BRAF mutation, and intraoperative frozen section in surgical decision‐making of thyroid nodules. Diagnostic Cytopathology. https://doi.org/10.1002/dc.25135
Vancouver
Zhu Z, Su C, Chen G, Wan F, Jin M, Duan X, et al. Significance of FNAC , BRAF mutation, and intraoperative frozen section in surgical decision‐making of thyroid nodules. Diagnostic Cytopathology. 2023. doi:10.1002/dc.25135
BibTeX
@article{Zhu2023,
author = {Zhu, Zhaohui and Su, Chang and Chen, Guang and Wan, Fang and Jin, Meishan and Duan, Xiumei and Wang, Yongxiang and Wang, Guimin},
title = {Significance of FNAC , BRAF mutation, and intraoperative frozen section in surgical decision‐making of thyroid nodules},
journal = {Diagnostic Cytopathology},
year = {2023},
doi = {10.1002/dc.25135}
}
EUVIMED